AWARDDELIVERY ORDEROther than small business
Delivery order HHSN26800003H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC.
Overview
Award facts
- Net obligations
- $12.95M
- $12,953,436of $12.95M potential value
- Outlays (paid to date)
- $6.89M
- $6.89M paid of $12.95M obligated$6,889,648
- Period of performance
- Aug 30, 2016 to Feb 28, 2026
- Ended
- Modifications
- 10
- Latest action Dec 31, 2025
- Contract type
- Delivery order
- PIID HHSN26800003
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
IGF::OT::IGF THE NATIONAL MYELODYSPLASTIC SYNDROMES (MDS) NATURAL HISTORY STUDY, CENTRAL LAB AND BIOREPOSITORY (CLB), TASK ORDER 03, SEPTEMBER 1, 2016-FEBRUARY 28, 2018
Dates and value
- Award date
- Signed on Aug 30, 2016
- Potential end of performance
- Feb 27, 2026
- Current value
- $12,953,436Base and exercised options
- Potential value (if all options are exercised)
- $12,953,436
- Parent contract vehicle
- HHSN268201400003I (IDC, single award) — 3 orders recorded under it
Obligations by fiscal year of action
- FY2024: $1,186,324
- FY2022: $2,220,981
- FY2020: $4,438,388
- FY2018: $2,973,923
- FY2016: $2,133,819
Total across 5 fiscal years: $12,953,436
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Dec 31, 2025. View on USAspending · Recipient on SAM.gov
Recipient
LocationTAMPA, FL
UEIDVHKP4N619V9
CAGE code1X4B9
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate tax exempt
Business types and certifications
Nonprofit organizationTax-exempt corporation
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NHLBI
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NHLBI
- Funded from
- National heart, lung, and blood institute (0872)Program activities075-0872Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Tampa, Hillsborough, Florida 33612-9416
- Congressional district (place of performance)
- FL-15As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN11HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH (research and development)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Cost no feeS
- Offers received
- 5
Contract details
- Major program
- The national myelodysplastic syndromes (MDS) natural history study- central laboratory and bioreposi
- Certified cost or pricing data
- No
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not a bundled requirementD
- Consolidated requirement
- No
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Aug 30, 2016Base obligation at award: $2,133,819
- Latest action
- Dec 31, 2025 — Supplemental agreement (within scope)Modification P00010
- Latest substantive action
- Dec 31, 2025 — Supplemental agreement (within scope)Modification P00010
- Actions by type
- Base award1
- Supplemental agreement (within scope)7
- Change order2
- Other administrative action1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Delivery orderC
- Parent vehicle type
- IDCB
- Parent vehicle: multiple or single award
- Single awardS
- Parent vehicle agency
- National Institutes Of Health7529
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N920
- Transactions recorded under this award key
- 11
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N920
- Treasury accounts
- 075-2018/2018-0872-000
- 075-2020/2020-0872-000
- 075-2022/2022-0872-000
- 075-2024/2024-0872-000
- Object classes
- 25.5: Research and development contracts
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression